Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Renal-Injury'

Renal-Injury published presentations and documents on DocSlides.

Renal Fraction Filtration Fraction
Renal Fraction Filtration Fraction
by alida-meadow
Fig. 25.5. Fig 25.1. Net Filtration Pressure (NFP...
Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?
Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?
by tatyana-admore
Expert Panelists. Program Goals. Evaluating CV Ri...
2018 Annual Data Report
2018 Annual Data Report
by natalia-silvester
Volume 1: Chronic Kidney Disease. 2018 Annual Dat...
Disorders of Calcium Metabolism:
Disorders of Calcium Metabolism:
by stefany-barnette
Hypercalcemia. Steven Chessler, MD, Ph.D.. March,...
Excretion of Liquid Waste
Excretion of Liquid Waste
by lindy-dunigan
Chapter 49. By: Kayla . Nida. This system is need...
The Excretory System http://www.youtube.com/watch?v=qxb2_d9ilEw
The Excretory System http://www.youtube.com/watch?v=qxb2_d9ilEw
by lois-ondreau
REGULATION. Excretory & Nervous Systems. Regu...
Dyspepsia: an underestimated problem among end-stage renal disease patients
Dyspepsia: an underestimated problem among end-stage renal disease patients
by cheryl-pisano
Paulo Santos. Federal . University. . of. Cearร...
New Oral Anticoagulants: A Review
New Oral Anticoagulants: A Review
by phoebe-click
Babak Moini, MD. Veterans Affairs Hospital. Noon ...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by alexa-scheidler
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
ANESTHESIA FOR TURP, TURBT AND NEPHRECTOMY
ANESTHESIA FOR TURP, TURBT AND NEPHRECTOMY
by jane-oiler
MODERATED BY-DR GIRISH. PRESENTED BY-DR CHITTRA. ...
CV Risk Management in Diabetes: A Mandate for GLP-1 Receptor Agonists?
CV Risk Management in Diabetes: A Mandate for GLP-1 Receptor Agonists?
by pamella-moone
Introduction/Overview. Lowering HbA1c Reduces the...
GLP-1 Agonist Clinical Case Challenge: Intensifying Therapy and Improving Management of T2D
GLP-1 Agonist Clinical Case Challenge: Intensifying Therapy and Improving Management of T2D
by stefany-barnette
Program Goal. Case Presentation: Diane. Case Pres...
Gout Gout The most common cause of inflammatory arthritis in US adults (3.9% of Americans; approx.
Gout Gout The most common cause of inflammatory arthritis in US adults (3.9% of Americans; approx.
by alexa-scheidler
Prevalence is greater in men (5.9%; 6.1 million) ...
Gout The term gout describes a disease spectrum including
Gout The term gout describes a disease spectrum including
by tatyana-admore
hyperuricemia. , . recurrent attacks of acute art...
Dysmorphology CHO NICU Lecture
Dysmorphology CHO NICU Lecture
by kittie-lecroy
Prepared by PJ. 12-16-11. Syndromes to Know. Tris...
Learning From Defects Through Sensemaking
Learning From Defects Through Sensemaking
by min-jolicoeur
AHRQ Safety Program for Surgery. Implementation. ...
Urinary System Learning Objectives:
Urinary System Learning Objectives:
by marina-yarberry
Define terms relating to the urinary system. Desc...
Alexander Olinger , PharmD
Alexander Olinger , PharmD
by mitsue-stanley
PGY-2 Oncology Pharmacy Resident. Pharmacy Grand...
SICKLE CELL ANEMIA in JOB CORPS
SICKLE CELL ANEMIA in JOB CORPS
by pamella-moone
Gary Strokosch, MD. Jane Litvin, MS. Introduction...
Urinary System Learning Objectives:
Urinary System Learning Objectives:
by tatiana-dople
Define terms relating to the urinary system. Desc...
Kidney stones Dr Kushma Nand
Kidney stones Dr Kushma Nand
by lois-ondreau
Renal Physician. General aspects of stone formati...
The major issues in the renal diet across Europe
The major issues in the renal diet across Europe
by test
The European diet. Christa Nagel, . 09-05-2014. c...
Approach to the patient
Approach to the patient
by min-jolicoeur
. with. . chronic. . kidney. . disease. Gรผlร...
Phase 1: Focus on Acute Care Hospitals
Phase 1: Focus on Acute Care Hospitals
by briana-ranney
(2008). . (2008-Present). Working Group Structu...
Jennifer Morris, PharmD, BCPPS, BCPS, FCCM
Jennifer Morris, PharmD, BCPPS, BCPS, FCCM
by mitsue-stanley
Clinical Pharmacy Specialist โ€“ Renal. Texas Chi...
Pediatric abdominal masses
Pediatric abdominal masses
by jane-oiler
1-. Abdominal masses are common in infants and ch...
Kidney stones Chapter 55
Kidney stones Chapter 55
by lois-ondreau
Pages 1591-1596. By: Heather Wacholz BSN,RN,CCRN-...
SSc 101 Julia Rhiannon June 2013
SSc 101 Julia Rhiannon June 2013
by celsa-spraggs
j. ulia.rhiannon@va.gov. outline. Intro and patho...
HONORS ANATOMY & PHYSIOLOGY
HONORS ANATOMY & PHYSIOLOGY
by lois-ondreau
CHAPTER 25. THE URINARY SYSTEM. PART 3. ยฉ 2013 P...
Hypertension in Pregnancy
Hypertension in Pregnancy
by lois-ondreau
Teresa G. Berg, M.D.. Maternal-Fetal Medicine. Un...
1 Membranoproliferative
1 Membranoproliferative
by faustina-dinatale
Glomerulonephritis. . MPGN is . characterizedby....
CONCEPT OF CLEARANCE
CONCEPT OF CLEARANCE
by marina-yarberry
DEPARTMENT . OF PHARMACEUTICS. . ...
Metastatic Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
by myesha-ticknor
Program Goals. Incidence of RCC in the United Sta...
Abdominal Vascular Surgery
Abdominal Vascular Surgery
by min-jolicoeur
Summary. Abdominal Vascular Surgery. A & P. P...
Fluids and Electrolytes Emily Miller, MD
Fluids and Electrolytes Emily Miller, MD
by sherrill-nordquist
What We Will Discuss. Major electrolytes, too low...
Physiologic Changes in Pregnancy
Physiologic Changes in Pregnancy
by briana-ranney
Heather M. Said, DO. Assistant Professor, Materna...
NON-RENAL INDICATIONS: INTOXICATIONS & INBORN ERRORS OF METABOLISM
NON-RENAL INDICATIONS: INTOXICATIONS & INBORN ERRORS OF METABOLISM
by phoebe-click
STEFANO PICCA, MD. Dialysis Unit- Dept . of Nephr...
Geriatric Anesthesia Robert L.
Geriatric Anesthesia Robert L.
by tatyana-admore
Snyder, DO, FAOCA. Evaluate potential risk factor...
Renal Replacement Therapies
Renal Replacement Therapies
by natalia-silvester
John Hsieh, M.D.. Coast Nephrology Medical Group....
๋ณต๋ง‰ํˆฌ์„๊ณผ ์‹ ์žฅ์ด์‹
๋ณต๋ง‰ํˆฌ์„๊ณผ ์‹ ์žฅ์ด์‹
by natalia-silvester
๊ณ ๋ ค๋Œ€ํ•™๊ต ์˜๊ณผ๋Œ€ํ•™ ์•ˆ์‚ฐ๋ณ‘์› . ์‹ ์ž...